EIP hires litigation partner from Teva

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

EIP hires litigation partner from Teva

jones-m-45.jpg

UK firm EIP has hired Matthew Jones as a partner in its London office, in the latest in a string of expansive moves by the firm

M Jones

Jones (right) joins from Teva Pharmaceuticals Europe where he worked on patent litigation, including Generics [UK] v Yeda & Teva over the drug Copaxone. The Court of Appeal ruled on the case in July 2013.

Jones has worked on other patent areas in the past, including electronics and telecoms. He worked alongside EIP's head of litigation Gary Moss at both McDermott Will & Emery and Taylor Wessing.

EIP opened an office in the US in May 2013, in San Diego – the first UK IP law firm to do so. It has also said it will open an office in Düsseldorf, Germany later this year.

The firm now has 18 partners, of which five work on litigation under the EIP Legal side of the firm. The remainder are patent and trade mark attorneys.

more from across site and SHARED ros bottom lb

More from across our site

François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Gift this article